GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $689,000 | +14.5% | 15,830 | +14.5% | 0.06% | +27.5% |
| Q1 2022 | $602,000 | +16.7% | 13,822 | +18.2% | 0.05% | +10.9% |
| Q4 2021 | $516,000 | +41.4% | 11,693 | +22.4% | 0.05% | +27.8% |
| Q3 2021 | $365,000 | +301.1% | 9,550 | +320.1% | 0.04% | +300.0% |
| Q2 2021 | $91,000 | +93.6% | 2,273 | +72.9% | 0.01% | +50.0% |
| Q1 2021 | $47,000 | -76.7% | 1,315 | -76.1% | 0.01% | -80.0% |
| Q4 2020 | $202,000 | -51.7% | 5,492 | -50.5% | 0.03% | -60.0% |
| Q3 2020 | $418,000 | -3.5% | 11,099 | +4.6% | 0.08% | -19.4% |
| Q2 2020 | $433,000 | +19.0% | 10,610 | +10.3% | 0.09% | -7.9% |
| Q1 2020 | $364,000 | +600.0% | 9,619 | +770.5% | 0.10% | +621.4% |
| Q4 2019 | $52,000 | +550.0% | 1,105 | +500.5% | 0.01% | +366.7% |
| Q3 2019 | $8,000 | -52.9% | 184 | -57.3% | 0.00% | -57.1% |
| Q2 2019 | $17,000 | – | 431 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |